UnitedHealth Group Inc. (UNH) Chief Executive Officer, Optum Patrick Hugh Conway acquired 91 shares of common stock on September 22, 2026, as dividend equivalents paid on outstanding restricted stock units. The equivalents are subject to the same terms as the underlying units and are forfeited if those units do not vest. His direct holdings following the transaction were 15,419 shares. No Rule 10b5-1 plan is reported.
UnitedHealth Group Inc. Chief Financial Officer Wayne S. DeVeydt acquired 106 shares of common stock as dividend equivalents paid on outstanding restricted stock units on September 22, 2026. His directly held common stock position following the transaction was 18,676 shares. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if those units do not vest. No Rule 10b5-1 plan is reported.
UnitedHealth Group Inc. (UNH) Chief Executive Officer, UHC Noel Timothy John acquired 84 shares of common stock on September 22, 2026 as dividend equivalents paid on outstanding restricted stock units. His direct common-stock holdings following the transaction were 17,735 shares. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if those units do not vest.
UnitedHealth Group Inc. EVP & Chief People Officer Erin McSweeney reported acquiring 53 shares of common stock on September 22, 2026, representing dividend equivalents paid on outstanding restricted stock units. The equivalents are subject to the same terms as the underlying units and are forfeited if those units do not vest. Her reported direct holdings following the transaction were 15,654 shares.
UnitedHealth Group Inc. (UNH) announced that senior leaders will participate in an interview-format discussion at the Wells Fargo 21st Annual Healthcare Conference on September 9, 2026, beginning at 8:00 a.m. Eastern Time. Topics will include the company’s strategy, market positions, recent results and expectations for its end markets.
A live audio webcast of the conference appearance will be accessible through the Investor Relations page of the company’s website. The company states that this communication is being provided under Regulation FD and that the information described is furnished rather than filed under federal securities laws.
UNITEDHEALTH GROUP INC (UNH) reported that Chief Financial Officer Wayne S. DeVeydt had 1,208.895 shares of common stock disposed of on September 2, 2026 in a transaction classified as a payment of exercise price or tax liability by delivering or withholding securities. The shares were treated as held directly, and his reported direct holdings after this transaction were 18,569.525 shares of UNH common stock. No Rule 10b5-1 trading plan is reported for this transaction.
UNITEDHEALTH GROUP INC (UNH) reported that Patrick Hugh Conway, Chief Executive Officer, Optum, sold 1,169 shares of Common Stock on 2026-08-21 in a sale described as an open market or private transaction at $390.00 per share. Following this transaction, he directly holds 15,327.797 shares of UNH common stock.
UNITEDHEALTH GROUP INC (UNH) received a Rule 144 notice for a planned sale of its common stock by officer Patrick H. Conway. The filing lists 1,169 shares of UNH common stock held in a Fidelity Brokerage Services LLC account with an aggregate market value of $455,910.00 as of 08/21/2026, and notes 897,594,847 shares of UNH common stock outstanding. It also reports a prior sale of 500 shares for $205,000.00 on 08/05/2026 and identifies additional shares tied to restricted stock vesting from compensation on several 2026 dates.
UnitedHealth Group Inc. executive Dennis Andrew Stankiewicz, Chief Accounting Officer, reported a Form 4 transaction involving Common Stock. On 2026-08-11, 233.402 shares were delivered or withheld at $402.19 per share as payment of exercise price or tax liability. Following this disposition, he directly holds 10,057.567 shares, which include shares received through UnitedHealth Group Incorporated's Employee Stock Purchase Plan.
UnitedHealth Group reported solid second‑quarter 2026 results with total revenues of $112.0 billion, roughly flat year over year, while profitability improved sharply. Net earnings attributable to common shareholders rose to $5.48 billion from $3.41 billion, and diluted EPS increased to $6.04 from $3.74.
For the first six months of 2026, revenues were $223.8 billion, up 1%, with net earnings attributable to shareholders of $11.76 billion, up 21%. Operating performance improved as the medical care ratio declined to 86.7% from 89.4% and the operating margin expanded to 7.1% from 4.6%. Operating cash flow was very strong at $20.0 billion in the first half.
Membership declined, with UnitedHealthcare medical enrollment down to 48.5 million, including 9% reductions in Medicare Advantage and Medicaid lives, reflecting funding pressures, pricing and benefit actions, and state eligibility changes. Optum Health revenues fell 5% on fewer value‑based care patients, though segment earnings increased on cost management and reserve releases. The company raised its annualized dividend to $9.28 per share, repurchased about 10.5 million shares year‑to‑date, reduced long‑term debt, and completed portfolio divestitures while planning a $3.0 billion health care acquisition.